Recent studies on lung cancer revealed that c-MYC is a key downstream effector of FGF/FGFR-dependent signaling in response to oxidative stress, and that FGFR inhibition induced apoptosis through c-MYC downregulation [152]. Here, MYC is linked to lung carcinoma.